Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats

Surg Neurol. 2005 Oct;64(4):355-61. doi: 10.1016/j.surneu.2005.03.036.

Abstract

Background: This report examines the dose-dependent effects of melatonin on early lipid peroxidation levels, ultrastructural changes, and neurological function in experimental spinal cord injury (SCI) by comparing them with therapeutic levels of methylprednisone in rats.

Methods: SCI was performed by an aneurysm clip placed extradurally at the level of T10. Rats were randomly divided into six groups of 10 rats each. Group 1 (sham) received only laminectomy; group 2 (control) received SCI; group 3 (placebo) received SCI and physiological saline; group 4 received methylprednisone (30 mg/kg); groups 5 and 6 received melatonin at doses of 50 or 100 mg/kg, respectively, after SCI. Rats were neurologically tested 24 hours after trauma. Spinal cord samples were harvested for both lipid peroxidation levels and ultrastructural histopathological evaluation.

Results: Neurological scores of rats were not different in SCI groups. Lipid peroxidation levels are significantly restricted only in methylprednisone group at 24 hours. Melatonin-treated groups showed more ultrastructural improvement on electron microscope studies when compared with methylprednisone group. However, the therapeutic effects of melatonin were mainly observed on white matter of spinal cord in ultrastructural investigation. There was significant difference between melatonin dose groups increasing with dose.

Conclusions: Results showed that melatonin has no significant dose-dependent effects on early lipid peroxidation bur rather some neuroprotective effects on both axons and myelin sheaths of white matter in ultrastructural observations when compared with methylprednisone. These effects significantly augmented with dose increase.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Axons / drug effects
  • Axons / pathology
  • Axons / ultrastructure
  • Cytoprotection / drug effects
  • Cytoprotection / physiology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Lipid Peroxidation / drug effects
  • Lipid Peroxidation / physiology
  • Melatonin / pharmacology*
  • Melatonin / therapeutic use
  • Methylprednisolone / pharmacology
  • Methylprednisolone / therapeutic use
  • Microscopy, Electron, Transmission
  • Myelin Sheath / drug effects
  • Myelin Sheath / pathology
  • Myelin Sheath / ultrastructure
  • Nerve Fibers, Myelinated / drug effects*
  • Nerve Fibers, Myelinated / pathology
  • Nerve Fibers, Myelinated / ultrastructure
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Rats
  • Rats, Wistar
  • Spinal Cord Injuries / drug therapy*
  • Spinal Cord Injuries / pathology
  • Spinal Cord Injuries / physiopathology
  • Treatment Outcome
  • Wallerian Degeneration / drug therapy*
  • Wallerian Degeneration / pathology
  • Wallerian Degeneration / prevention & control

Substances

  • Anti-Inflammatory Agents
  • Neuroprotective Agents
  • Melatonin
  • Methylprednisolone